[Rhinoconjunctivitis. Highly selective therapy using topical H1-blockers].
D018926:Anti-Allergic Agents / Q000627:therapeutic use*; D003233:Conjunctivitis, Allergic / Q000150:complications* / Q000188:drug therapy / Q000276:immunology; D006634:Histamine H1 Antagonists / Q000627:therapeutic use*; D006801:Humans; D017835:Nedocromil / Q000627:therapeutic use*; D010880:Piperidines / Q000627:therapeutic use*; D012221:Rhinitis, Allergic, Perennial / Q000150:complications* / Q000188:drug therapy / Q000276:immunology
D018926:Anti-Allergic Agents; D006634:Histamine H1 Antagonists; D010880:Piperidines; D017835:Nedocromil; C047340:levocabastine